kund
3 minutes ago
Why do you trust this CEO so much? He blatantly lied to shareholders at the ASM, saying the Rett trial design was being discussed at the Rett conference, but nothing came of it. The same goes for 3-71—he promised a readout this year, but now we know part A isn’t even completed after six months, and